dest4real:


It's most likely EB1A won't fly. The criteria is heavy, and they don't seem to agree with pieces of evidence presented.

Poprnapoleon:


You are good to go.. why notry both EB1A and EB2.. I got approval for both with similar profile

gare2510:


Same thing happening in TRANSCORP PLC; case of thunder striking your goat in the farm and pig in the house same day and time

donshady:


Thier mutual fund seems to be the worst of Thier investment. They hardly improve on Thier rates, customer care services is zero.

seyisanya:
I like the way you're so adamant with your market convictions despite the fact that people find it difficult to accept it. It's kinda funny when @CP made a declaration of bull weeks ago, his comment was bombarded with ''likes'' but the moment he returned with a different message from his ''bedsheet'', people no wan gree again. Indeed, nah serious no gree 4 anybody this 2024! Lol

onegentleguy:


Am sorry Sir.
I will share when I will. ...I always do!

But the content of the outline and any guide related thereof is strictly for those who subscribed for it.
Many are members here, hence the reason for the post and other previous updates.

Do take care of you.
Regards

yMcy56:

Na so humans be.
Everywhere silent now as their Portfolios dey put smiles on their faces, let pullback of few days show face, na insults and stones go dey follow.....

Akerewe:


Is it an offer for subscription?

Wiseoldman:


Hello, did you get a feedback yet? I think it takes up to a month, but just checking if anyone got any info yet.

Frangel:


For further insights, please do you mind sharing the Scheme document or a link if available online.

From the attached, it looks like they would treat the N17.42 and payout from retained earnings as dividend distribution; 10% WHT applies.

This GSK transaction seems to be a big win for shareholders. From the Q32023 financials to date, a further N9.40 per share (more by FY2023 if results are maintained) would be returned as capital. A final payment (if any) is also possible before conclusion.

My takes.

As advised by them, exercise caution in dealing with GSK shares going forward.

Streetinvestor2:
WHT on the payment that doesn't look good.why WHT on the money when all the money to shareholders is not profit or dividend.
Pls share the scheme document

Wiseoldman:


Hello, did you get a feedback yet? I think it takes up to a month, but just checking if anyone got any info yet.

potent5:
Autonomy nonsense. As if they can generate their own revenue. You want to be autonomous on top revenue generated mostly by the executive.

RayRay06677:


It's my first sukuk, equally waiting for this answer,

Thanks a million for answering

Iamzik:


At what cost?

A bottle of Groundut in Lagos sells for as much as 1,600.

Same groundnut that we plant in Nigeria o. We better start importing

Beremx:
Why is milk and dairy products not included? I thought Buhari also banned it to force us to be drinking raw nunu from cows?
Tinubu should include milk please. The product is very expensive

Melcapital:

Dangote foods was discussed consistently for many pages, so were Transcorp, First bank, many others. Let's allow people learn from what relates to their situation or interests. These conversations keep the forum alive.

- Replied with good intentions and not to invalidate/disrespect another's opinion.

Mpeace:
Fire on the mounting. Tomorrow na tomorrow.
I am waiting for someone to come here and tell us how he sold all of his holdings today at maximum profit.